Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cohesion a speculative buy say analysts:

This article was originally published in Clinica

Executive Summary

Biosurgical products company Cohesion Technologies has been given a speculative buy recommendation by Taglich Brothers, which specialises in companies with a market capitalisation of less than $250 million. Taglich gives the company, currently standing at $4.28, a three-year target price of $21.25. The New York company's products, which are used during surgery to stop bleeding, to prevent leakage of air or fluids, for the repair and attachment of tissues and to prevent the formation of adhesions after surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072134

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel